Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Marimed (MRMD) Change in Taxes (2021 - 2025)

Marimed (MRMD) has disclosed Change in Taxes for 5 consecutive years, with $2.7 million as the latest value for Q3 2025.

  • On a quarterly basis, Change in Taxes rose 310.84% to $2.7 million in Q3 2025 year-over-year; TTM through Sep 2025 was $11.1 million, a 266.13% increase, with the full-year FY2024 number at $7.5 million, up 154.26% from a year prior.
  • Change in Taxes was $2.7 million for Q3 2025 at Marimed, up from $691000.0 in the prior quarter.
  • In the past five years, Change in Taxes ranged from a high of $15.6 million in Q4 2021 to a low of -$10.1 million in Q2 2022.
  • A 5-year average of $1.7 million and a median of $1.2 million in 2021 define the central range for Change in Taxes.
  • Peak YoY movement for Change in Taxes: tumbled 178.12% in 2023, then surged 1061.67% in 2024.
  • Marimed's Change in Taxes stood at $15.6 million in 2021, then tumbled by 101.12% to -$174000.0 in 2022, then surged by 341.38% to $420000.0 in 2023, then soared by 1061.67% to $4.9 million in 2024, then tumbled by 44.85% to $2.7 million in 2025.
  • Per Business Quant, the three most recent readings for MRMD's Change in Taxes are $2.7 million (Q3 2025), $691000.0 (Q2 2025), and $2.8 million (Q1 2025).